Thyroid No Surgery 101: Radiofrequency Ablation for Autonomously Functioning Thyroid Nodules

Thyroid No Surgery 101: Radiofrequency Ablation for Autonomously Functioning Thyroid Nodules

Thyroid No Surgery 101: Radiofrequency Ablation for Autonomously Functioning Thyroid Nodules

Thyroid No Surgery 101: Radiofrequency Ablation for Autonomously Functioning Thyroid Nodules. No surgery or Radioiodine.

Dr.Guttler’s comments:

  1. 44 patients from 5 institutions who refused or were not suitable for surgery or radioiodine therapy.
  2. Twenty-three patients were affected by a toxic nodule and 21 by a pretoxic nodule AFTNs.
  3. After 20 months size decreased from 18 to 4 ml.
  4. Thyroid function improved.
  5. 35 hot nodules became cold or were normal when scanned and 9 decreased uptake, although they remained hot nodules.
  6. Symptom and cosmetic scores were significantly reduced at the last follow-up.
  7. No major complications were encountered.
  8. The efficacy and safety of RF ablation for treating AFTN; RF ablation can be considered an alternative to surgery or radioiodine therapy.
  9. Call me for details how you can avoid radiation and surgery for your AFTN or Toxic nodule.
  10. 310-393-8860 or thyropid.manager@protonmail.com.
  11. DrG.

Radiofrequency Ablation for Autonomously Functioning Thyroid Nodules: A Multicenter Study

Published Online:https://doi.org/10.1089/thy.2014.0100

Background: The purpose of this study is to validate the generalizability of the efficacy and safety of radiofrequency (RF) ablation for treating autonomously functioning thyroid nodules (AFTN) in a large population multicenter study.

Twenty-three patients were affected by a toxic nodule and 21 by a pretoxic nodule. RF ablation was performed using an 18-gauge, internally cooled electrode. Nodule volume, thyroid function, scintigraphy, symptom/cosmetic scores, and complications were evaluated before treatment and during each follow-up.

Results: The mean follow-up period was 19.9±12.6 months. The mean nodule volume was initially 18.5±30.1 mL and significantly decreased after treatment at 1 month (11.8±26.9 mL, p<0.001) and the last month (4.5±9.8 mL, p<0.001). Significant improvement of triiodothyronine, free thyroxine, and thyrotropin was observed at the last follow-up. Regarding scintigraphy, 35 hot nodules became cold or were normal when scanned and 9 decreased uptake, although they remained hot nodules. The mean symptom and cosmetic scores were significantly reduced at the last follow-up. No major complications were encountered.

Conclusions: This multicenter study validated the efficacy and safety of RF ablation for treating AFTN; RF ablation can be considered an alternative to surgery or radioiodine therapy.

Add Your Comment

Contact Info
1328 16th Street, Santa Monica, CA 90404
Monday – Friday
9:00 AM to 5:00 PM
(310) 393-8860